Meta-analysis of major bleeding with uninterrupted warfarin compared to interrupted warfarin and heparin bridging in ablation of atrial fibrillation

International Journal of Cardiology

Volumn 187, Issue 1, 2015, Pages 426-429

  Nairooz, Ramez ^a   Sardar, Partha ^b   Payne, Jason ^a   Aronow, Wilbert S ^c   Paydak, Hakan ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Ablation; Anticoagulation; Atrial fibrillation; Bleeding; Thrombo embolism

Indexed keywords

HEPARIN; INTERRUPTED WARFARIN; LOW MOLECULAR WEIGHT HEPARIN; UNCLASSIFIED DRUG; UNINTERRUPTED WARFARIN; WARFARIN; ANTICOAGULANT AGENT;

ANTICOAGULATION; ATRIAL FIBRILLATION; BLEEDING; CASE CONTROL STUDY; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; DRUG EFFICACY; DRUG SAFETY; HUMAN; LETTER; META ANALYSIS (TOPIC); OBSERVATIONAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; COMPARATIVE STUDY; META ANALYSIS; POSTOPERATIVE HEMORRHAGE; SEVERITY OF ILLNESS INDEX;

ANTICOAGULANTS; ATRIAL FIBRILLATION; CATHETER ABLATION; HEPARIN; HUMANS; POSTOPERATIVE HEMORRHAGE; SEVERITY OF ILLNESS INDEX; WARFARIN;

EID: 84929224538     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.03.376     Document Type: Article

References (16)

1. H. Calkins, K.H. Kuck, R. Cappato, J. Brugada, A.J. Camm, S.A. Chen, H.J. Crijns, R.J. Damiano Jr., D.W. Davies, J. DiMarco, J. Edgerton, K. Ellenbogen, M.D. Ezekowitz, D.E. Haines, M. Haissaguerre, G. Hindricks, Y. Iesaka, W. Jackman, J. Jalife, P. Jais, J. Kalman, D. Keane, Y.H. Kim, P. Kirchhof, G. Klein, H. Kottkamp, K. Kumagai, B.D. Lindsay, M. Mansour, F.E. Marchlinski, P.M. McCarthy, J.L. Mont, F. Morady, K. Nademanee, H. Nakagawa, A. Natale, S. Nattel, D.L. Packer, C. Pappone, E. Prystowsky, A. Raviele, V. Reddy, J.N. Ruskin, R.J. Shemin, H.M. Tsao, D. Wilber, Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society, Heart Rhythm. 9 (2012) 632-696 (e21).
2. P. Santangeli, L. Di Biase, R. Horton, J.D. Burkhardt, J. Sanchez, A. Al-Ahmad, R. Hongo, S. Beheiry, R. Bai, P. Mohanty, W.R. Lewis, A. Natale, Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications: Evidence from a meta-analysis, Circ. Arrhythm. Electrophysiol. 5 (2) (Apr. 2012) 302-311.
3. L. Di Biase, J.D. Burkhardt, P. Santangeli, P. Mohanty, J.E. Sanchez, R. Horton, G.J. Gallinghouse, S. Themistoclakis, A. Rossillo, D. Lakkireddy, M. Reddy, S. Hao, R. Hongo, S. Beheiry, J. Zagrodzky, B. Rong, S. Mohanty, C.S. Elayi, G. Forleo, G. Pelargonio, M.L. Narducci, A. Dello Russo, M. Casella, G. Fassini, C. Tondo, R.A. Schweikert, A. Natale, Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: Results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial, Circulation 129 (25) (Jun 2014) 2638-2644.
4. A. Arshad, C.K. Johnson, S. Mittal, E. Buch, I. Hamam, T. Tran, R.E. Shaw, D. Musat, M. Preminger, T. Sichrovsky, B. Herweg, K. Shivkumar, J. Hummel, J.S. Steinberg, Comparative safety of periablation anticoagulation strategies for atrial fibrillation: Data from a large multicenter study, Pacing Clin. Electrophysiol. 37 (6) (2014) 665-673.
5. L. Di Biase, F. Gaita, E. Toso, P. Santangeli, P. Mohanty, N. Rutledge, X. Yan, S. Mohanty, C. Trivedi, R. Bai, J. Price, R. Horton, G.J. Gallinghouse, S. Beheiry, J. Zagrodzky, R. Canby, J.F. Leclercq, F. Halimi, M. Scaglione, F. Cesarani, R. Faletti, J. Sanchez, J.D. Burkhardt, A. Natale, Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation with open irrigated catheters? Results from a prospective multicenter study, Heart Rhythm. 11 (2014) 791-798.
6. S.P. Page, N. Herring, R.J. Hunter, E. Withycombe, M. Lovell, G. Wali, T.R. Betts, Y. Bashir, M. Dhinoja, M.J. Earley, S.C. Sporton, K. Rajappan, R.J. Schilling, Periprocedural stroke risk in patients undergoing catheter ablation for atrial fibrillation on uninterrupted warfarin, J. Cardiovasc. Electrophysiol. 25 (2014) 585-590.
7. T. Kuwahara, A. Takahashi, Y. Takahashi, A. Kobori, S.Miyazaki, A. Takei, T. Fujino, K. Okubo, K. Takagi, A. Fujii, M. Takigawa, Y. Watari, H. Hikita, A. Sato, K. Aonuma, Prevention of periprocedural ischemic stroke andmanagement of hemorrhagic complications in atrial fibrillation ablation under continuous warfarin administration, J. Cardiovasc. Electrophysiol. 24 (2013) 510-515.
8. E.B. Saad, I.P. Costa, R.E. Costa, L.A. Inácio Jr., C. Slater, A. Camiletti, D.G. Moura Neto, P. Maldonado, L.E. Camanho, C.A. Polanczky, Safety of ablation for atrial fibrillation with therapeutic INR: Comparison with transition to low-molecular-weight heparin, Arq. Bras. Cardiol. 97 (2011) 289-296.
9. J.M. Tapanainen, F. Braunschweig, J. Schwieler, P. Insulander, H. Bastani, N. Drca, G. Kennebäck, B. Sadigh, M. Jensen-Urstad, Continuous warfarin therapy is safe and feasible in catheter ablation of atrial fibrillation, Scand. Cardiovasc. J. 47 (2013) 109-113.
10. L. Di Biase, J.D. Burkhardt, P. Mohanty, J. Sanchez, R. Horton, G.J. Gallinghouse, D. Lakkireddy, A. Verma, Y. Khaykin, R. Hongo, S. Hao, S. Beheiry, G. Pelargonio, A. Dello Russo, M. Casella, P. Santarelli, P. Santangeli, P. Wang, A. Al-Ahmad, D. Patel, S. Themistoclakis, A. Bonso, A. Rossillo, A. Corrado, A. Raviele, J.E. Cummings, R.A. Schweikert, W.R. Lewis, A. Natale, Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: The impact of periprocedural therapeutic international normalized ratio, Circulation 121 (2010) 2550-2556.
11. S. Gautam, R.M. John,W.G. Stevenson, R. Jain, L.M. Epstein, U. Tedrow, B.A. Koplan, S. McClennen, G.F. Michaud, Effect of therapeutic INR on activated clotting times, heparin dosage, and bleeding risk during ablation of atrial fibrillation, J. Cardiovasc. Electrophysiol. 22 (2011) 248-254.
12. A. Hakalahti, P. Uusimaa, K. Ylitalo, M.J. Raatikainen, Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment, Europace 13 (2011) 640-645.
13. J.J. Kwak, H.N. Pak, J.K. Jang, S.K. Kim, J.H. Park, J.I. Choi, C. Hwang, Y.H. Kim, Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation, J. Cardiovasc. Electrophysiol. 21 (2010) 620-625.
14. S.P. Page, M.S. Siddiqui, M. Finlay, R.J. Hunter, D.J. Abrams, M. Dhinoja, M.J. Earley, S.C. Sporton, R.J. Schilling, Catheter ablation for atrial fibrillation on uninterrupted warfarin: Can it be done without echo guidance? J. Cardiovasc. Electrophysiol. 22 (2011) 265-270.
15. O.M.Wazni, S. Beheiry, T. Fahmy, C. Barrett, S. Hao, D. Patel, L. Di Biase, D.O. Martin, M. Kanj, M. Arruda, J. Cummings, R. Schweikert, W. Saliba, A. Natale, Atrial fibrillation ablation in patients with therapeutic international normalized ratio: Comparison of strategies of anticoagulation management in the periprocedural period, Circulation 116 (2007) 2531-2534.
16. R.A. Winkle, R.H. Mead, G. Engel, M.H. Kong, R.A. Patrawala, Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: Comparison of aspirin, warfarin, dabigatran, and rivaroxaban, Europace 16 (10) (2014) 1443-1449.